Abstract

BackgroundImprovement in acromegaly management increased disease survival and prevalence. Evidence regarding acromegaly in older adults are sparse. We aim to explore acromegaly impact on aging process quality.MethodsMulticenter case-control study conducted on 42 older adults (≥ 65 years) acromegaly patients (ACRO) compared to an age- and gender-matched control group (CTR). Each participant underwent a multidimensional geriatric evaluation.ResultsMean age in both groups was 73 ± 6 years and female gender was most represented (69%). All comorbidities were more frequent in ACRO than CTR. Thirteen ACRO were in remission and 29 had active disease controlled by medical therapy except for one patient. ACRO showed worse physical performance and mobility skills worsening with age as compared to CTR. ACRO performed poorly in functional status assessment, and age negatively correlated with instrumental and basic daily activities execution. Cognitive evaluation scores were significantly lower in ACRO vs. CTR, worsening with age. No difference was found concerning nutritional and psychological status. Musculoskeletal and bone diseases were more frequent in ACRO than in CTR (52% vs. 12%; 64% vs. 10%; P < 0.05) and independently associated with geriatric outcomes in ACRO. ACRO reported a less satisfactory quality of life concerning physical activity and pain, general health, vitality, social activities.ConclusionsOur study demonstrates increased frailty of older acromegaly patients as compared to non-acromegaly patients with a consequent negative impact on their quality of life. Therefore, it seems advisable to include physical, functional, cognitive, nutritional, and psychological status assessments in routine clinical practice. Further studies are needed to identify the most appropriate geriatric tools.

Highlights

  • Improvement in acromegaly management increased disease survival and prevalence

  • Medications number was significantly higher in acromegaly patients (ACRO) as compared to control group (CTR) (8 ± 3 vs. 3 ± 2), without significant differences regarding antidepressant/antipsychotic drugs

  • We demonstrated that scores related to physical performance, mobility skills and sarcopenia worsen with age, suggesting a synergistic effect between aging and acromegaly, accounting for an increased frailty in older acromegaly patients

Read more

Summary

Introduction

Improvement in acromegaly management increased disease survival and prevalence. We aim to explore acromegaly impact on aging process quality. Gagliardi et al BMC Geriatr (2021) 21:598 approaches, surgical techniques, medical therapies over the years has increased acromegaly survival and prevalence in all age groups [17,18,19,20,21]. Recent epidemiological data suggest a reduction in acromegaly mortality with death causes more similar to those of the general population of corresponding age. Hatipoglu et al have underlined the importance of a geriatric multidimensional assessment in older patients with acromegaly since the disease may enhance some aspects of the aging process (cognitive dysfunction, malnutrition risk, reduced physical performance, mood impairment) [2]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call